Psychopharmacologic Management of Anxiety in an Adolescent with Congenital Long QT Syndrome

Barsheshet A , Dotsenko O , Goldenberg I : Congenital long QT syndromes: Prevalence, pathophysiology and management. Paediatr Drugs, 16:447–56, 2014.

Beach SR , Kostis WJ , Celano CM , Januzzi JL , Ruskin JN , Noseworthy PA , Huffman JC : Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation. J Clin Psychiatry, 75:e441–e449, 2014.

Beesdo K , Knappe S , Pine DS : Anxiety and anxiety disorders in children and adolescents: Developmental issues and implications for DSM-V. Psychiatr Clin North Am, 32:483–524, 2009.

Celexa^® [package insert]. St. Louis, MO: Forest Laboratories, Inc; 2014.

Connolly SD , Bernstein GA : Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry, 46:267–83, 2007.

Czaja AS , Valuck RJ , Anderson HD : Comparative safety of selective serotonin reuptake inhibitors among pediatric users with respect to adverse cardiac events. Pharmacoepidemiol Drug Saf, 22:607–614, 2013.

Delgado SV , Strawn JR , Padapati EV : Contemporary Psychodynamic Psychotherapy for Children and Adolescents: Integrating Intersubjectivity and Neuroscience. New York: Springer Publishing, 2015.

Funk KA , Bostwick JR : A comparison of the risk of QT prolongation among SSRIs. Ann Pharmacother, 47:1330–1341, 2013.

Goldenberg I , Horr S , Moss AJ , et al.: Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals. J Am Coll Cardiol, 57:51–59, 2011.

Maron BJ , Zipes DP : 36^th Bethesda Conference: Eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol, 45:1313–1375, 2005.

Posner K , Brown GK , Stanley B , Brent DA , Yershova K V , Oquendo MA , Currier GW , Melvin GA , Greenhill L , Shen S , Mann JJ : The Columbia-Suicide Severity Rating Scale: Initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry, 168:1266–77, 2011.

Reinblatt SP , DosReis S , Walkup JT , Riddle MA : Activation adverse events induced by the selective serotonin reuptake inhibitor fluvoxamine in children and adolescents. J Child Adolesc Psychopharmacol, 19:119–126, 2009.

Schwartz PJ , Crotti L , Insolia R : Long-QT syndrome: From genetics to management. Circ Arrhythm Electrophysiol, 5:868–77, 2012.

Shear MK , Rucci P , Williams J , Frank E , Grochocinski V , Vander Bilt J , Houck P , Wang T : Reliability and validity of the Panic Disorder Severity Scale: replication and extension. J Psychiatr Res, 35:293–296, 2001.

Strawn JR , Welge JA , Wehry AM , Keeshin B , Rynn MA : Efficacy and tolerability of antidepressants in pediatric anxiety disorders: A systematic review and meta-analysis. Depress Anxiety, 32:149–157, 2015.

Woosley RL , Romero KA , www.Crediblemeds.org, QTdrugs List, July 2015, AZCERT, Inc. 1822 Innovation Park Dr., Oro Valley, AZ 85755.